abstracts sponsored symposia

Abstracts of the 9th Congress of the

European Society of Contraception

 

“Improving

life quality through contraception and reproductive

health care” 

3-6 MAY 2006

ISTANBUL/ TURKEY

Sponsored Symposium 1 (Schering) Health and more – Added benefits in every stage of life
Sponsored Symposium 2 (Wyeth) Possibilities and Challenges with Oral Contraceptives
Sponsored Symposium 3 (Organon) NuvaRing® — From Science to Satisfaction
Sponsored Symposium 4

(Grünenthal)

Contraceptive management in clinical practice – A challenge


Sponsored Symposium 1 (Schering) Abstracts
Health and more – Added benefits in

every stage of life

Chair: D. Cibula (Czech Rep.), Co-chair: S. Özalp (Turkey)

• 

Welcome & Introduction to the topic of the symposium – D.

Cibula (Czech Republic)

• 

Yasminelle – It’s not only a new OC – D. Gruber (Austria)

• 

Changing contraceptive needs in different life stages of a Mirena user

– D. Mansour (UK)

• 

New Guidelines on Menorrhagia Treatment – R. Hurskainen (Finland)

• 

Angeliq: Considering cardiovascular health in the Menopause – T.

Mikkola (Finland)

• 

Discussion & Closing Remarks – S. Özalp (Turkey)

Sponsored Symposium 2

(Wyeth)

 

Possibilities and Challenges with

Oral Contraceptives

 

Chair: S. Skouby (Denmark)

• 

Non-Contraceptive Benefits of Oral Contraception – A.T. Teichmann

(Germany)

• 

Menstrual Cycle Suppression – F. Fruzzetti (Italy)

• 

Epidemiology and Treatment of PMS/PMDD – S. Skouby (Denmark)

Sponsored Symposium 3 (Organon)

 

NuvaRing® — From Science to

Satisfaction

Chair: C. Benedetto (Italy), Co-chair: B. Oddens (The Netherlands)

• 

Scientific backbone – paradigm shift from dose to exposure

E. Ng (USA)

Abstract

• 

A balancing act – I. Milsom (Sweden)

Abstract

• 

Providing a logical choice for your patient – R. Nappi (Italy)

Abstract

Sponsored

Symposium 4 (Grünenthal)

 

Contraceptive

management in clinical practice – A challenge

Chair: Th. Rabe (Germany)

• 

Introduction – Th. Rabe (Germany)

• 

How to choose the most appropriate contraceptive method – J.

Bitzer (Switzerland)

• 

Skin and hair problems – only cosmetically relevant? – P. van de

Weijer (The Netherlands)

• 

Compliance – A question of expectations and consulting? – U.H.

Winkler (Germany)

• 

Belara® – A new opportunity in contraception – U. Gaspard (Belgium)

• 

Discussion

home

Scroll to Top